DK1147119T3 - 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer - Google Patents

2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer

Info

Publication number
DK1147119T3
DK1147119T3 DK00900088T DK00900088T DK1147119T3 DK 1147119 T3 DK1147119 T3 DK 1147119T3 DK 00900088 T DK00900088 T DK 00900088T DK 00900088 T DK00900088 T DK 00900088T DK 1147119 T3 DK1147119 T3 DK 1147119T3
Authority
DK
Denmark
Prior art keywords
monosaccharides
cell adhesion
adhesion inhibitors
isopropylidene derivatives
isopropylidene
Prior art date
Application number
DK00900088T
Other languages
Danish (da)
English (en)
Inventor
Sudershan K Arora
Nawal Kishore
Jang Bahadur Gupta
Vishwas D Joshi
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Application granted granted Critical
Publication of DK1147119T3 publication Critical patent/DK1147119T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK00900088T 1999-01-15 2000-01-10 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer DK1147119T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (fr) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors
PCT/IB2000/000022 WO2000042054A1 (fr) 1999-01-15 2000-01-10 Derives 2, 3-o isopropylidene de monosaccharides inhibant l'adhesion cellulaire

Publications (1)

Publication Number Publication Date
DK1147119T3 true DK1147119T3 (da) 2004-01-19

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00900088T DK1147119T3 (da) 1999-01-15 2000-01-10 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer

Country Status (31)

Country Link
US (5) US6590085B1 (fr)
EP (1) EP1147119B1 (fr)
JP (1) JP2002534530A (fr)
CN (1) CN1167707C (fr)
AR (1) AR022235A1 (fr)
AT (1) ATE250074T1 (fr)
AU (1) AU768511B2 (fr)
BG (1) BG105745A (fr)
BR (1) BR0007553A (fr)
CA (1) CA2359986A1 (fr)
CO (1) CO5180591A1 (fr)
CR (1) CR6423A (fr)
CZ (1) CZ20012540A3 (fr)
DE (1) DE60005300T2 (fr)
DK (1) DK1147119T3 (fr)
ES (1) ES2206176T3 (fr)
HK (1) HK1041270A1 (fr)
HR (1) HRP20010529B1 (fr)
HU (1) HUP0105116A3 (fr)
ID (1) ID30351A (fr)
IN (1) IN190975B (fr)
MA (1) MA25342A1 (fr)
MX (1) MXPA01007187A (fr)
MY (1) MY121135A (fr)
NZ (2) NZ512852A (fr)
PA (1) PA8489901A1 (fr)
PT (1) PT1147119E (fr)
SK (1) SK284241B6 (fr)
TR (1) TR200102043T2 (fr)
WO (1) WO2000042054A1 (fr)
YU (1) YU50701A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (fr) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
RS20050890A (en) 2003-05-30 2007-12-31 Ranbaxy Laboratories Limited, Substituted pyrrole derivatives
EP1789428A1 (fr) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Derives de monosaccharide
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
EP1915160A2 (fr) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derives de monosaccharides pour le traitement de copd et de la rhinite allergique
AU2006313430B2 (en) * 2005-11-08 2012-09-06 Ranbaxy Laboratories Limited Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
US20070238716A1 (en) * 2006-03-14 2007-10-11 Murthy Ayanampudi S R Statin stabilizing dosage formulations
EP1842855A3 (fr) * 2006-03-29 2007-12-05 Ranbaxy Laboratories Limited Dérivés de monosaccharide en tant qu'agnets antiinflammaotoires et/ou agents anticancéreux
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
EP1953170A1 (fr) * 2006-10-03 2008-08-06 Ranbaxy Laboratories Limited Dérivés de monosaccharide en tant qu'agents anti-inflammatoires
AU2008221506B2 (en) * 2007-09-20 2011-01-20 ResMed Pty Ltd Retractable Tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) * 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (fr) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
US20040019191A1 (en) 2004-01-29
AR022235A1 (es) 2002-09-04
AU768511B2 (en) 2003-12-18
US7005516B2 (en) 2006-02-28
TR200102043T2 (tr) 2001-11-21
CA2359986A1 (fr) 2000-07-20
MY121135A (en) 2005-12-30
SK284241B6 (en) 2004-11-03
US20040029820A1 (en) 2004-02-12
AU1886100A (en) 2000-08-01
CR6423A (fr) 2004-03-09
US7037899B2 (en) 2006-05-02
JP2002534530A (ja) 2002-10-15
US7005422B2 (en) 2006-02-28
HRP20010529B1 (en) 2005-02-28
ES2206176T3 (es) 2004-05-16
CN1167707C (zh) 2004-09-22
CN1343213A (zh) 2002-04-03
US20040018995A1 (en) 2004-01-29
EP1147119B1 (fr) 2003-09-17
MA25342A1 (fr) 2001-12-31
EP1147119A1 (fr) 2001-10-24
HUP0105116A2 (hu) 2003-04-28
HUP0105116A3 (en) 2003-05-28
BG105745A (en) 2002-05-31
SK10132001A3 (sk) 2002-01-07
ID30351A (id) 2001-11-22
IN190975B (fr) 2003-09-06
WO2000042054A1 (fr) 2000-07-20
MXPA01007187A (es) 2002-04-24
HK1041270A1 (en) 2002-07-05
PA8489901A1 (es) 2000-09-29
NZ527483A (en) 2005-02-25
DE60005300T2 (de) 2004-07-15
US20040023900A1 (en) 2004-02-05
NZ512852A (en) 2004-02-27
PT1147119E (pt) 2004-02-27
CZ20012540A3 (cs) 2002-02-13
DE60005300D1 (de) 2003-10-23
ATE250074T1 (de) 2003-10-15
YU50701A (sh) 2005-06-10
BR0007553A (pt) 2001-12-18
HRP20010529A2 (en) 2002-08-31
CO5180591A1 (es) 2002-07-30
US6590085B1 (en) 2003-07-08

Similar Documents

Publication Publication Date Title
NO20022649L (no) Heterocykliske dihydropyrimidiner som kaliumkanal inhibitorer
DK1049662T3 (da) Inhibitorer af alpha4-medieret celleadhæsion
NO20012701D0 (no) Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter
NO20014642L (no) Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
DK1315694T3 (da) Inhibitorer af alpha-4-medieret celleadhæsion
NO20022573L (no) N6-heterosykliske, 8-modifiserte adenosinderivater
NO20050665L (no) Pyrrolidonderivater som MAOE inhibitoere
FI951001A0 (fi) Sulfatoituja alfa-glykolipidijohdannaisia soluadheesioinhibiittoreina
DK1100797T3 (da) Heterocycliske forbindelser som inhibitorer af rotamaseenzymer
DK1144425T3 (da) Derivater af monosaccharider som celleadhæsionsinhibitorer
DK1060178T3 (da) Heterocyklisk forbindelser som inhibitorer af rotamase enzymer
NO20022125D0 (no) Pyrrolderivater som inhibitorer for fosfodiesterase VII
DK1226143T3 (da) Imidazopyridinderivater som phosphodiesterase VII-inhibitorer
DK1228073T3 (da) Imidazolforbindelser som phosphodiesterase VII-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
DK1147119T3 (da) 2,3-O-isopropylidenderivater af monosaccharider som celleadhæsionsinhibitorer
NO20021959L (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
DK1104762T3 (da) Substituerede imidazo[1,2a]aziner som selektive COX-2-inhibitorer
NO20014234D0 (no) Pyrazol-3-on-derivater som faktor-Xa-inhibitorer
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer
EP1389200A4 (fr) Derives de n-arylsulfonyl-proline substitues utilises comme inhibiteurs puissants de l'adhesion cellulaire
NO20016403D0 (no) Substituerte purinderivater som inhibitorer av celleadhesjon
FI951002A0 (fi) Sulfatoituja beta-glykolipidijohdannaisia soluadheesioinhibiittoreina